Company / Capital Returned to Shareholders
ACCENDRA HEALTH INC/VA/ Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$10.2M
FY2025
5-year range
$0 / $10.2M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0 to $10M over the past 3 years.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of +73.5%.
Improved from $0 to $10M over the past 3 years.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +73.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +73.5%, indicating consistent growth.
- Peak capital returned to shareholders was recorded in FY2016.
- Lowest capital returned to shareholders in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.2M | - |
| FY2024 | - | - |
| FY2023 | $0 | - |
| FY2022 | $0 | -100.0% |
| FY2021 | $5.2M | +706.5% |
| FY2020 | $648.0K | -98.7% |
| FY2019 | $48.2M | +0.0% |
| FY2018 | $48.2M | -29.3% |
| FY2017 | $68.2M | -49.3% |
| FY2016 | $134.4M | +60.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026